Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
To assess short-term risk for severe cardiovascular events (excluding myocarditis and pericarditis) after COVID-19 vaccination, adults younger than 75 years hospitalized for PE, acute MI, hemorrhagic stroke, or ischemic stroke (73,325 events) were reviewed in relation to a 1st or 2nd COVID vaccine dose. No association was found between the Pfizer–BioNTech or Moderna vaccine and severe cardiovascular events. The first dose of the Oxford–AstraZeneca vaccine was associated with acute MI and PE in the second week after vaccination. An association with MI in the second week after a single dose of the Janssen vaccine could not be ruled out.
Cardiology September 6th 2022
JAMA Network
The USPSTF comes to the conclusion that statin use has at least a moderate net benefit for adults aged 40 to 75 who have no prior history of CVD, at least one CVD risk factor, and an estimated 10-year CVD event risk of 10% or greater. There is at least a marginal net benefit from using statins to prevent CVD events and all-cause mortality in adults aged 40 to 75 who have no prior history of CVD, at least one of these risk factors, and an estimated 10-year CVD event risk of 7.5% to less than 10%. Still, is the evidence enough?
MDLinx
The founding editor of Comprehensive Clinical Nephrology teases out for us our physiologic response to salt, sugar, fat, and water that creates a recipe for obesity – a recipe being used daily by many Americans with obvious results. His recommendation? “Drinking more water and reducing salt intake offer cheap, easy and healthy strategies that may prevent or treat obesity.” Click to see the evidence behind the conclusion.
Cleveland Clinic Journal of Medicine
This review with case example explores pericarditis and myocarditis and implications on limiting exercise. The authors summarize relevant guidelines and provide their own conclusion and guidance. They offer a helpful algorithm combining the ESC, ACC, and AHA guidelines and suggest an additional element around limiting heart rate during an acute inflammatory episode.
What is the best strategy for preventing stroke in patients with non-valvular AF: anticoagulants or left atrial appendage occlusion (LAAO)? The answer depends on the individual patient’s combination of stroke and bleeding risks. In this study, combined risks favored LAAO for higher bleeding risk, but that benefit became less certain at higher stroke risks.
Cardiology August 23rd 2022
MedPage Today
Watch the video podcast filmed in Paris or take the fast route and read the transcript.Rohin Francis, MBBS, takes a history trip with Adam Rodman, MD, of “Bedside Rounds”fame into the history of sound as a diagnostic tool.